Added to YB: 2025-08-06
Pitch date: 2025-08-01
ICCC [neutral]
ImmuCell Corporation
+1.97%
current return
Author Info
No bio for this author
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$54.7M
Pitch Price
$6.09
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.84
P/E
23.43
EV/Sales
2.32
Sector
Biotechnology
Category
growth
Phenom Capital | 2025 1H Portfolio Review - ImmuCell Corporation
ICCC (holding update): Market leader w/ decade of secular growth now has all three return engines revving: revenue growth, margin expansion, and multiple expansion - positioned for outsized returns in next few years. Significant upside potential from Retain approval that could transform company.
Read full article (1 min)